Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03934489 · ClinicalTrials.gov registry record · NA

Emotion Regulation Skills Training for Individuals With MS and Their Support Partners

A NA study of Multiple Sclerosis, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT03934489 is a NA study of Multiple Sclerosis that has completed, run by Johns Hopkins University. The registered enrollment target is 40 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03934489, a NA study of Multiple Sclerosis, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This pilot randomized controlled trial investigates a novel, group-based emotion regulation skills training intervention for reducing anxious and depressive symptomatology and improving emotion regulation and problem solving in individuals with MS and the individual's support partners. Participants will be randomized (1:1) to the intervention ("Partnered Emotion Regulation Skills Intervention and Supportive Teaching \[PERSIST\]") or to the active control (Facilitated Peer Support).

Conditions Studied

Interventions

  • BEHAVIORAL PERSIST
  • BEHAVIORAL Facilitated Peer Support

Study Locations (1)

Maryland

  • Johns Hopkins University - Baltimore

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2020-01-07
Est. Completion 2021-03-15
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT03934489

The ClinicalTrials.gov registry entry for NCT03934489 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (93% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which PERSIST is the first listed.

NCT03934489 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT03934489 about?

NCT03934489 is a clinical study titled "Emotion Regulation Skills Training for Individuals With MS and Their Support Partners". This pilot randomized controlled trial investigates a novel, group-based emotion regulation skills training intervention for reducing anxious and depressive symptomatology and improving emotion regulation and problem solving in individuals with MS and the individual's support partners. Participants ...

What is the current status of trial NCT03934489?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2020-01-07. Estimated completion is 2021-03-15.

What conditions does trial NCT03934489 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT03934489?

The interventions under investigation include: PERSIST (BEHAVIORAL), Facilitated Peer Support (BEHAVIORAL).

Who is sponsoring clinical trial NCT03934489?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03934489 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.